Election 2014
SENSEX NIFTY

Taro

Apr 09, 2014 at 12:49 | Source: Moneycontrol.com
So far, the only effective setback received by Sun Pharma is its plan to acquire a 100 percent stake in Taro, in 2010, which did not succeed.
Mar 28, 2014 at 21:22 | Source: CNBC-TV18
There were concerns that Sun Pharma, which has, in the past, faced opposition from minority shareholders of its Israeli subsidiary Taro, will see a fresh run-in during this extra-ordinary general meeting.
Mar 27, 2014 at 13:08 | Source: Moneycontrol.com
Fund managers have challenged the re-appointment of independent directors to Taro's board at a meeting September last year and want their own nominees.
Mar 06, 2014 at 15:22 | Source: CNBC-TV18
Suven Life Sciences today has granted an exclusive license and right to distribute and market its Malathion Lotion in USA, Canada and Mexico to Taro Pharmaceuticals North America, a subsidiary of Taro Pharmaceutical Industries.
Mar 06, 2014 at 15:17 | Source: Reuters
Sun also sought to take full control of its US-listed Israeli unit Taro Pharmaceutical Industries Ltd , but the deal was terminated last year after a long-drawn battle.
Mar 04, 2014 at 13:44 | Source: Moneycontrol.com
Suven Life Sciences today has granted an exclusive license and right to distribute and market its Malathion Lotion USP 0.5 percent w/v with US patent # 8,138,366 and ANDA 091559 in USA, Canada and Mexico to Taro Pharmaceuticals North America.
Mar 04, 2014 at 12:39 | Source: Moneycontrol.com
SUVEN Life Sciences today announced that it has granted an exclusive license and right to distribute and market its Malathion Lotion USP 0.5% w/v with US Patent # 8,138,366 and ANDA 091559 in USA, Canada and Mexico to Taro Pharmaceuticals North America, Inc., a subsidiary of Taro Pharmaceutical Industries Ltd.
Mar 04, 2014 at 09:08 | Source: Reuters
Japan's government, however, said it was still trying to figure out how the Tokyo-based company, once the world's biggest bitcoin exchange, could lose nearly half a billion dollars worth of the virtual currency in a short period, and whether crime was involved.
Feb 14, 2014 at 10:17 | Source: Moneycontrol.com
Sun Pharma has also received US FDA for its Abbreviated New Drug Application (ANDA) to market a generic version of Temodar, Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg.
Feb 13, 2014 at 16:09 | Source: Moneycontrol.com
Year-on-year net profit increased to Rs 1,531 crore from Rs 881.3 crore and revenues rose to Rs 4,312 crore from Rs 2,865.5 crore.
Messages on Taro »

R Jagannathan

Platinum Member

888 Followers

Ranbaxy Labs  

’s own track record. Ranbaxy may be the biggest acquisition to date, but each one of his previous acquisitions has also brought forth tough problems – among them Caraco Pharma, Taro and Dusa Pharma. He bought troubled companies and doggedly changed their growth trajectories. The ultimate takeout

11.06 AM Apr 9th

akumarsrao

New Member

0 Follower

Sun Pharmaceutical Industries  

I think Sun Pharma is getting a steal. If they can handle the US FDA issue, which I am sure they can, considering how patiently they handled Taro and won control. I would buy Sun Pharma with a view of doubling my return in 12-18 months. a. Sun gets a huge chunk of the domestic market b. A positive

5.02 PM Apr 7th

Web Messenger

Platinum Member

208305 Followers

Sun Pharma  

Source:Economic Times - Sun pharma`s acquisition of the beleaguered drug maker Ranbaxy is one of the best things to happen for investors - especially that of Ranbaxy in the immediate term. Sun Pharma has a proven track record of buying distressed assets and turning them around. Sun acquired Taro

4.29 PM Apr 7th

akumarsrao

New Member

0 Follower

Sun Pharma  

. Ranbaxy is also working on new HIV drugs for which it has some agreement with Gilead. I think Sun Pharma is getting a steal. If they can handle FDA issue, which I am sure they can, considering how patiently they handled Taro and won control.

3.34 PM Apr 7th

Stockie007

New Member

8 Followers

Sun Pharma  

Hi marketman,your analysis on Sun seems to be negative perception summary.Same things were said about Taro`s acquisition and it became a huge success within 6 months.In fact, it has even overtaken Sun

12.44 PM Apr 7th

Stockie007

New Member

8 Followers

Sun Pharma  

If Sun can make Ranbaxy as another Taro sky will be the limit for Sun. In fact even reaching 1500 within a year cannot be ruled out

10.05 AM Apr 7th

Stockie007

New Member

8 Followers

Sun Pharma  

Sun knows how to turn loss making company into a profit one.You don`t need any better example than TARO.As mentioned by Sun if they can reinstate USFDA confidence in Ranbaxy then it will be like 2 Sun

10.02 AM Apr 7th

PSHDESAI

Gold Member

4 Followers

Sun Pharma  

Blue Mountain and Iszo Capital are idiotic non-significant noise. Instead of being happy that their shares have risen multi-fold under the Sun management these idiots are just trying to undermine the hand which feeds them. They hold an insignificant amount of shares and most minority Taro

12.47 PM Mar 30th

PSHDESAI

Gold Member

4 Followers

Sun Pharma  

Seriously the news of taro facing investor revolt is fii operator driven to down the stock more diring a time os weakness in terms of dollar rate and minor negligible fda issues. The cyclical stocks seem to be getting ahead before the elections. In the long run a wise nvestor would accimulate

2.41 PM Mar 27th

asharafn

Silver Member

3 Followers

Sun Pharma  

sun pharma faces some kind of complications in its subsidiary taro. that share fell almost 5% in American market. The reflection is happening here as well

1.56 PM Mar 27th

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.